Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination

doi:10.1097/TP.0000000000003836

Comment

. 2021 Sep 1;105(9):e104-e106.

doi: 10.1097/TP.0000000000003836.

Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination

Nicole M Ali¹, Nasser Alnazari¹, Sapna A Mehta¹, Brian Boyarsky², Robin K Avery², Dorry L Segev², Robert A Montgomery¹, Zoe A Stewart¹

Affiliations

¹ Transplant Institute, NYU Langone Health, New York, NY.
² Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

PMID: 34049360
DOI: 10.1097/TP.0000000000003836

Comment

Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination

Nicole M Ali et al. Transplantation. 2021.

. 2021 Sep 1;105(9):e104-e106.

doi: 10.1097/TP.0000000000003836.

Authors

Nicole M Ali¹, Nasser Alnazari¹, Sapna A Mehta¹, Brian Boyarsky², Robin K Avery², Dorry L Segev², Robert A Montgomery¹, Zoe A Stewart¹

Affiliations

¹ Transplant Institute, NYU Langone Health, New York, NY.
² Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

PMID: 34049360
DOI: 10.1097/TP.0000000000003836

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no funding or conflicts of interest.

Comment on

Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, Garonzik-Wang JM. Boyarsky BJ, et al. JAMA. 2021 May 4;325(17):1784-1786. doi: 10.1001/jama.2021.4385. JAMA. 2021. PMID: 33720292 Free PMC article.
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, Garonzik-Wang JM. Boyarsky BJ, et al. JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489. JAMA. 2021. PMID: 33950155 Free PMC article.

Cited by

Solid organ transplantations and COVID-19 disease.
Yılmaz EA, Özdemir Ö. Yılmaz EA, et al. World J Transplant. 2021 Dec 18;11(12):503-511. doi: 10.5500/wjt.v11.i12.503. World J Transplant. 2021. PMID: 35070786 Free PMC article. Review.
Reconciling short-term clinical and immunological outcomes of SARS-CoV-2 vaccination in solid organ transplant recipients.
Bestard O, Jouve T, Castells L, Lopez M, Muñoz M, Crespo E, Toapanta N, Esperalba J, Campos-Varela I, Pont T, Len O, Campins M, Moreso F. Bestard O, et al. Am J Transplant. 2022 Feb;22(2):673-675. doi: 10.1111/ajt.16855. Epub 2021 Oct 5. Am J Transplant. 2022. PMID: 34554648 Free PMC article. No abstract available.
Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases.
Chauhan M, Nzeako I, Li F, Thuluvath PJ. Chauhan M, et al. Ann Hepatol. 2022 Jul-Aug;27(4):100702. doi: 10.1016/j.aohep.2022.100702. Epub 2022 Mar 23. Ann Hepatol. 2022. PMID: 35338012 Free PMC article.
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients.
Charmetant X, Espi M, Benotmane I, Barateau V, Heibel F, Buron F, Gautier-Vargas G, Delafosse M, Perrin P, Koenig A, Cognard N, Levi C, Gallais F, Manière L, Rossolillo P, Soulier E, Pierre F, Ovize A, Morelon E, Defrance T, Fafi-Kremer S, Caillard S, Thaunat O. Charmetant X, et al. Sci Transl Med. 2022 Mar 16;14(636):eabl6141. doi: 10.1126/scitranslmed.abl6141. Epub 2022 Mar 16. Sci Transl Med. 2022. PMID: 35103481 Free PMC article.
The Impact of Vaccination on Incidence and Outcomes of SARS-CoV-2 Infection in Patients with Kidney Failure in Scotland.
Bell S, Campbell J, Lambourg E, Watters C, O'Neil M, Almond A, Buck K, Carr EJ, Clark L, Cousland Z, Findlay M, Joss N, Metcalfe W, Petrie M, Spalding E, Traynor JP, Sanu V, Thomson P, Methven S, Mark PB. Bell S, et al. J Am Soc Nephrol. 2022 Apr;33(4):677-686. doi: 10.1681/ASN.2022010046. Epub 2022 Feb 2. J Am Soc Nephrol. 2022. PMID: 35110363 Free PMC article.

See all "Cited by" articles

References

1. Boyarsky BJ, Werbel WA, Avery RK, et al. Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients. JAMA. 2021;325:1784–1786.
1. Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325:2204–2206.
1. Zervou F, Ali N, Neumann H, et al. COVID-19 antibody tesponses in solid organ transplant recipients. 2020;7(suppl 1):S332.
1. Benotmane I, Gautier-Vargas G, Wendling MJ, et al. In-depth virological assessment of kidney transplant recipients with COVID-19. Am J Transplant. 2020;20:3162–3172.
1. Boyarsky BJ, Ou MT, Werbel WA, et al. Early development and durability of SARS-CoV-2 antibodies among solid organ transplant recipients: a pilot study. Transplantation. 2021;105:e52–e53.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Boyarsky BJ, Werbel WA, Avery RK, et al. Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients. JAMA. 2021;325:1784–1786.

[2] Boyarsky BJ, Werbel WA, Avery RK, et al. Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients. JAMA. 2021;325:1784–1786.

[3] Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325:2204–2206.

[4] Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325:2204–2206.

[5] Zervou F, Ali N, Neumann H, et al. COVID-19 antibody tesponses in solid organ transplant recipients. 2020;7(suppl 1):S332.

[6] Zervou F, Ali N, Neumann H, et al. COVID-19 antibody tesponses in solid organ transplant recipients. 2020;7(suppl 1):S332.

[7] Benotmane I, Gautier-Vargas G, Wendling MJ, et al. In-depth virological assessment of kidney transplant recipients with COVID-19. Am J Transplant. 2020;20:3162–3172.

[8] Benotmane I, Gautier-Vargas G, Wendling MJ, et al. In-depth virological assessment of kidney transplant recipients with COVID-19. Am J Transplant. 2020;20:3162–3172.

[9] Boyarsky BJ, Ou MT, Werbel WA, et al. Early development and durability of SARS-CoV-2 antibodies among solid organ transplant recipients: a pilot study. Transplantation. 2021;105:e52–e53.

[10] Boyarsky BJ, Ou MT, Werbel WA, et al. Early development and durability of SARS-CoV-2 antibodies among solid organ transplant recipients: a pilot study. Transplantation. 2021;105:e52–e53.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination

Affiliations

Development of COVID-19 Infection in Transplant Recipients After SARS-CoV-2 Vaccination

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous